DHRS2 and infectious otitis media: For the 10-valent pneumococcal NTHi protein D conjugate vaccine (PHiD-CV; SynflorixTM, GSK Vaccines, Rixensart, Belgium), a recently published randomized controlled trial (RCT) in Finland reported a trend towards reduced AOM.15